Proteomics Global Market estimated to be worth $27,670.3 million by 2026.

Proteomics is the qualitative and quantitative analysis of the entire protein complement of a cell, tissue, or organism under a specific, defined set of conditions. It involves the extensive study of structural and functional role in the regulation of a biological system involving protein-protein interaction, protein modification, protein function and their localization studies which are crucial in early disease detection, diagnosis, prognosis and monitoring the disease development.

According to IQ4I Research analysis, the proteomics global market is estimated to reach $27,670.3 million by 2026 growing at double digit CAGR from 2019 to 2026. The proteomics market is classified into product, application, end-user and geography. Proteomics product market is further classified into consumables, instruments, softwares & services and proteomics services. Consumables segment accounted for the largest revenue in 2019 growing at double digit CAGR from 2019 to 2026. The consumable market is further segmented into Chromatography consumables, Spectroscopy consumables, Electrophoresis consumables, Blotting consumables, Protein microarray consumables, X-ray crystallography consumables, Surface Plasmon resonance consumables and other consumables. Among consumables market, spectrometry consumables segment accounted for the largest revenue in 2019 and is expected grow at early teens CAGR from 2019 to 2026.

The factors driving the market are raising use of proteomics in drug discovery, development and manufacturing, increasing demand for personalized medicine, early disease detection, diagnosis and treatment, technological advancements favoring adoption of proteomics, growing availability of funds for research, whereas, factors such as high cost of instruments and special research materials maintaining consistency, reproducibility of result, lack of standardized workflow, complexity, lack of skilled professionals & data management options, ethical concern and regulatory issues are restraining the market growth.

Proteomics instruments market is segmented into Chromatography, Spectroscopy, Electrophoresis, Blotting, Protein microarrays, Flow cytometry, X-ray crystallography, Surface Plasmon resonance and others. Among these, spectrometry instrument accounted for the largest revenue in 2019, protein microarray segment is expected to grow at a strong double digit CAGR from 2019 to 2026.

Proteomics Service market is segmented into sample preparation and purification, characterization and quantification. Among these protein characterization segment accounted for the largest revenue in 2019 and is expected to grow at a high double digit CAGR from 2019 to 2026. The factors driving the market are increasing use of proteomics in drug discovery, development and manufacturing, increasing demand for personalized medicine, early disease detection, diagnosis and treatment, technological advancements favoring adoption of proteomics, growing availability of funds for research, whereas, factors such as high cost of instruments and special research materials such as quantification tags, dyes, antibodies etc., reproducibility of result, lack of standardized workflow, complexity, lack of skilled professionals & data management options, ethical concern and regulatory issues are restraining the market growth.

Based on application, the market is segmented into protein biomarker discovery, drug discovery development and manufacturing, Diagnostics, plant proteomics and others. Among these drug discovery, development & manufacturing segment accounted for the largest revenue in 2019 and is expected to grow at a double digit CAGR from 2019 to 2026 due to increased discovery of Protein biomarker leading to accelerated activities in new drug discovery, development and manufacturing for clinical research & development of personalized medicine, prevalence of chronic diseases, multidrug resistance microorganisms.

Proteomics end-user market is segmented into Pharma & Biotech, CRO'S, Diagnostic companies, Academic and & Research institutes. Among the end-users, Pharma & Biotech accounted for the largest revenue in 2019 due to extended research and development activities in biologics, drug development and manufacturing. The CROs segment is expected to grow with a strong double digit CAGR, this is attributed to the increased outsourcing activities for various process employed in protein research resulting in the establishment of various startups, research institutes with specialized technologies in North America and Europe. Further owing to the demand and accelerated research many contract research organizations in Asia-Pacific regions are into providing various services to service seekers in the field of proteomics.

Based on geography, the market is segmented into North America, Europe, Asia-Pacific and Rest of the world. Among these, North American region dominated the proteomics global market with a share in 2019 this is due to the accelerated technological advancements in analytical and informatics field, presence of major players, increased funding from both private and government agencies, growing awareness about benefits of proteomics in development of personalized medicine, presence advanced research institutes with specialized technologies, pharma biotech companies, government & private agencies concentrating on accelerating proteomics research. The Asia-Pacific region is the fastest-growing region with early teen CAGR from 2019 to 2026. This is attributed due to rising incidences of chronic diseases, government funding increasing toward proteomics research, development of companion diagnostics, presence of a large number of CROs and the emergence of this region as the manufacturing hub for biologics drugs.

Some of the companies are coming up with new technological advancements to maintain their leadership status in the proteomics for example In 2019, GE Healthcare has replaced AKTA Prime (FPLC) with AKTA go, a next-generation system allowing researchers to perform efficient routine protein purification which is connected with UNICORN control software automated FPLC hardware market, Thermo Fisher Scientific launched a new Krios solution designed to break down the barriers to cryo-EM adoption through improved ease-of-use, faster results and the most compact 300kV cryo-EM microscope design on the market.

The combination of four proteomics techniques is termed 4D proteomics (Depletion, Microscale solution isoelectric focusing, 1D SDS-polyacrylamide gel electrophoresis, LC-MS). For example: Bruker launched timsTOF Pro coupled with the revolutionary PASEF acquisition mode is not only breaking new boundaries in speed, sensitivity, selectivity and robustness, but also enabling 4D proteomic approaches, allowing scientists to routinely explore parts of the proteome not previously accessible.

The proteomics market is consolidated with the top 11 players occupying 50.8% of the market share and the remaining 49.2% of the market is occupied by other players and service providers. The key players in Proteomics Global Market include Thermo Fisher Scientific (U.S.), Danaher Corporation. (U.S.), Becton, Dickinson and Company (U.S.), Merck KGaA (Germany), Bruker Corporation (U.S.), Bio-Rad Laboratories, Inc. (U.S.), GE Healthcare (U.S.), Waters Corporation (U.S.) Abcam PLC.(U.K.), Agilent Technologies (U.S.), PerkinElmer (U.S.) and others. Acquisition, expansion and product launch are some of the strategies opted by the companies for maintaining their leadership position in this market. For example: Cambridge life science power player Abcam is acquiring Expedeon’s Proteomics and Immunology business by paying €120 million cash to expand its offerings into the fast-growing conjugation segment.